Center for Scientific Review; Notice of Closed Meetings, 30083-30084 [2015-12546]

Download as PDF Federal Register / Vol. 80, No. 100 / Tuesday, May 26, 2015 / Notices Implementing the National Nutrition Research Roadmap The ICHNR will distribute this Roadmap to encourage all relevant federal departments and agencies to coordinate human nutrition research programs to identify solutions to critical, nutrition-related, chronic disease prevention and health promotion issues. The aim is to have participating departments and agencies develop specific goals, objectives, and strategies based on the Roadmap and to identify their unique and collaborative roles, responsibilities, and the required resources and timeframes to accomplish those research goals. Given the strong trans-agency interests in a number of these areas of research, we hope to foster several coordinated research efforts to address research gaps and opportunities identified in this Roadmap and monitor their progress. We also hope the dissemination of these critical research gaps and opportunities will inspire the broader scientific community—at all developmental stages—to accelerate advances in human nutrition research to help improve and sustain the health of all Americans. Information Requested including whether the focus is clinical or basic sciences. If you are a member of a particular advocacy or professional organization, please indicate the name and primary focus of your organization (i.e., research support, patient care, etc.) and whether you are responding on behalf of your organization (if not, please indicate your position within the organization). Please provide your name and email address. Privacy Act Notification Statement: We are requesting your comments on the Draft National Nutrition Research Roadmap 2015–2020: Advancing Nutrition Research to Improve and Sustain Health. The information you provide may be disclosed to ICHNR staff and to contractors working on our behalf. Submission of this information is voluntary. However, the information you provide will help to categorize responses by scientific area of expertise, organizational entity or professional affiliation. Collection of this information is authorized under 42 U.S.C. 203, 24 1, 2891–1 and 44 U.S.C. 310 I and Section 30 l and 493 of the Public Health Service Act regarding the establishment of the National Institutes of Health, its general authority to conduct and fund research and to provide training assistance, and its general authority to maintain records in connection with these and its other functions. Dated: May 19, 2015. Lawrence A. Tabak, Deputy Director, National Institutes of Health. General Information mstockstill on DSK4VPTVN1PROD with NOTICES This Notice invites public comment on the Draft National Nutrition Research Roadmap 2015–2020: Advancing Nutrition Research to Improve and Sustain Health. Input is being sought regarding the Roadmap’s key questions, topics, research gaps and opportunities, and the short- and longterm research and resource initiatives that would address those gaps and opportunities. DEPARTMENT OF HEALTH AND HUMAN SERVICES All of the following fields in the response are optional and voluntary. Any personal identifiers will be removed when responses are compiled. Proprietary, classified, confidential, or sensitive information should not be included in your response. This Notice is for planning purposes only and is not a solicitation for applications or an obligation on the part of the United States (U.S.) government to provide support for any ideas identified in response to it. Please note that the U.S. government will not pay for the preparation of any comment submitted or for its use of that comment. Please indicate if you are one of the following: Investigator, administrator, student, patient advocate, Dean/or Institutional administrator, NIH employee, or other. If you are an investigator, please indicate your career level and main area of research interest, VerDate Sep<11>2014 17:50 May 22, 2015 Jkt 235001 [FR Doc. 2015–12628 Filed 5–22–15; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 30083 Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Innovative Immunology Research. Date: June 19, 2015. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Andrea Keane-Myers, BS, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4218, Bethesda, MD 20892, 301–435–1221, andrea.keane-myers@nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Therapeutic Approaches to Genetic Diseases Study Section. Date: June 23–24, 2015. Time: 4:00 p.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Four Seasons Hotel Seattle, 99 Union Street, Seattle, WA 98101. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 20892, 301–435– 1779 riverase@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Development—1 Study Section. Date: June 24, 2015. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Admiral Fell Inn, 888 South Broadway, Baltimore, MD 21231. Contact Person: Jonathan Arias, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5170, MSC 7840, Bethesda, MD 20892, 301–435– 2406, ariasj@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Acute Neural Injury and Epilepsy Study Section. Date: June 24–25, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Seetha Bhagavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 237– 9838, bhagavas@csr.nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Social Sciences and Population Studies B Study Section. Date: June 24, 2015. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, DC 20037. Contact Person: Karin F Helmers, Ph.D., Scientific Review Officer, Center for E:\FR\FM\26MYN1.SGM 26MYN1 mstockstill on DSK4VPTVN1PROD with NOTICES 30084 Federal Register / Vol. 80, No. 100 / Tuesday, May 26, 2015 / Notices Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892, (301) 254– 9975, helmersk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–RM– 14–030: Nuclear Organization and Function Interdisciplinary Consortium (NOFIC) (U54). Date: June 24–25, 2015. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Kee Hyang Pyon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7806, Bethesda, MD 20892, pyonkh2@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; SBIR/STTR Informatics. Date: June 24, 2015. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Melinda Jenkins, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3156, MSC 7770, Bethesda, MD 20892, 301–437– 7872, jenkinsml2@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–14– 166: Early Phase Clinical Trials in Imaging and Image-Guided Interventions. Date: June 24, 2015. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Chiayeng Wang, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Room 5213, MSC 7852, Bethesda, MD 20892, 301–435–2397, chiayeng.wang@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Innovative Therapies and Tools for Screenable Disorders in Newborns. Date: June 24, 2015. Time: 12:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: Four Seasons Hotel Seattle, 99 Union Street, Seattle, WA 98101. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 20892, 301–435– 1779, riverase@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) VerDate Sep<11>2014 17:50 May 22, 2015 Jkt 235001 Dated: May 19, 2015. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–12546 Filed 5–22–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Announcement of Requirements and Registration for: ‘‘Harnessing Insights From Other Disciplines To Advance Drug Abuse and Addiction Research’’ Challenge Authority: 15 U.S.C. 3719. The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), is seeking from the general public ideas on how to adapt specialized knowledge from other disciplines to inform new directions and discoveries in drug abuse and addiction research. With the ‘‘Harnessing insights from other disciplines to advance drug abuse and addiction research’’ challenge (the ‘‘Challenge’’), NIDA aims to gain insights into new methods or approaches that could transform discovery in order to significantly expand our basic knowledge about drug abuse and addiction processes, accelerate the development of novel and more effective prevention and treatment strategies, and/or enhance our capacity to implement, monitor, and improve upon evidence-based interventions. This Challenge is soliciting written proposals that outline novel approaches to addressing research challenges in the drug use and addiction field by leveraging concepts or technologies from other disciplines. This Challenge is being issued as part of NIDA’s strategic planning process for 2016–2020. Winning proposals may be used to guide the development of new research programs within NIDA. DATES: (1) Submission Period begins May 26, 2015, 9:00 a.m., EST (2) Submission Period ends June 22, 2015, 11:59 p.m., EST (3) Judging Period June 23, 2015 to July 17, 2015 (4) Winners Announced July 30, 2015 FOR FURTHER INFORMATION CONTACT: Dr. Emily Einstein, Ph.D., Science Policy Branch, Office of Science Policy and Communication, National Institute on Drug Abuse, Phone: 301–443–6071, Email: emily.einstein@nih.gov. SUPPLEMENTARY INFORMATION: SUMMARY: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Subject of the Challenge For the past four decades, the National Institute on Drug Abuse (NIDA) has led the way in supporting research to prevent and treat drug abuse and addiction and to mitigate the impact of their consequences, which include the spread of HIV/AIDS and other infectious diseases. To confront the most pressing aspects of the complex disease of addiction and to tackle its underlying causes, NIDA’s strategic approach is multipronged and includes research programs in basic, clinical, and translational sciences. These programs support studies in genetics, functional neuroimaging, social neuroscience, medication and behavioral therapies, prevention, and health services, including costeffectiveness research. NIDA’s evolving portfolio has produced a vast body of knowledge that informs strategic directions for future research, and this Challenge represents a new approach to broaden the pool of testable ideas. Scientific knowledge about drug addiction and its treatment has increased markedly over the past couple of decades. Today, we have a better understanding of the effects of drugs on the brain, as well as new and more effective treatments than were available in the past. A changing healthcare landscape may provide opportunities to further enhance the quality of addiction prevention and treatment. Still, addiction remains a pressing public health issue, and this Challenge seeks to accelerate progress in the field of drug abuse and addiction research by incentivizing a broader community of stakeholders—including those not formally involved in biomedical or addiction-related disciplines—to propose new ideas or innovations that leverage concepts or technologies from other disciplines to advance drug abuse and addiction research. While preparing their proposals, applicants should bear in mind NIDA’s traditional priority areas, persistent roadblocks that hamper progress, and evolving and emerging opportunities. Some illustrative examples are discussed below; however, proposals may address any challenge within the drug use and addiction field. NIDA priority areas. NIDA’s charge, to bring the power of science to bear on drug abuse and addiction, has two critical components. The first is the strategic support and conduct of research across a broad range of disciplines. The second is ensuring the rapid and effective dissemination and implementation of the results of that research to significantly improve E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

[Federal Register Volume 80, Number 100 (Tuesday, May 26, 2015)]
[Notices]
[Pages 30083-30084]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12546]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Innovative Immunology Research.
    Date: June 19, 2015.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Andrea Keane-Myers, BS, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4218, Bethesda, MD 20892, 301-
435-1221, andrea.keane-myers@nih.gov.

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Therapeutic Approaches to Genetic Diseases Study 
Section.
    Date: June 23-24, 2015.
    Time: 4:00 p.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Four Seasons Hotel Seattle, 99 Union Street, Seattle, WA 
98101.
    Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 
20892, 301-435-1779 riverase@csr.nih.gov.

    Name of Committee: Cell Biology Integrated Review Group; 
Development--1 Study Section.
    Date: June 24, 2015.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Admiral Fell Inn, 888 South Broadway, Baltimore, MD 
21231.
    Contact Person: Jonathan Arias, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5170, MSC 7840, Bethesda, MD 
20892, 301-435-2406, ariasj@csr.nih.gov.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Acute Neural Injury and Epilepsy Study 
Section.
    Date: June 24-25, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Seetha Bhagavan, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 
20892, (301) 237-9838, bhagavas@csr.nih.gov.

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Social Sciences and Population Studies B 
Study Section.
    Date: June 24, 2015.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, 
DC 20037.
    Contact Person: Karin F Helmers, Ph.D., Scientific Review 
Officer, Center for

[[Page 30084]]

Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 3148, MSC 7770, Bethesda, MD 20892, (301) 254-9975, 
helmersk@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA-RM-14-030: Nuclear Organization and Function 
Interdisciplinary Consortium (NOFIC) (U54).
    Date: June 24-25, 2015.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Kee Hyang Pyon, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5148, MSC 7806, Bethesda, MD 
20892, pyonkh2@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; SBIR/STTR Informatics.
    Date: June 24, 2015.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Melinda Jenkins, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3156, MSC 7770, Bethesda, MD 
20892, 301-437-7872, jenkinsml2@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-14-166: Early Phase Clinical Trials in Imaging and Image-
Guided Interventions.
    Date: June 24, 2015.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Chiayeng Wang, Ph.D., Scientific Review Officer, 
Center for Scientific Review, 6701 Rockledge Drive, Room 5213, MSC 
7852, Bethesda, MD 20892, 301-435-2397, chiayeng.wang@nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Innovative Therapies and Tools for Screenable Disorders in 
Newborns.
    Date: June 24, 2015.
    Time: 12:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Four Seasons Hotel Seattle, 99 Union Street, Seattle, WA 
98101.
    Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 
20892, 301-435-1779, riverase@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: May 19, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-12546 Filed 5-22-15; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.